Avalo Therapeutics, Inc. - AVTX

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
04/02/2026 10b5-1	04/03/2026	Sullivan Christopher Ryan Chief Financial Officer CFO	Sell	-7,980 @ $17.15	($136,823.11)	17,338	(-31.52%)	Direct
04/01/2026 10b5-1	04/03/2026	Sullivan Christopher Ryan Chief Financial Officer CFO	Sell	-7,979 @ $16.77	($133,769.91)	25,318	(-23.96%)	Direct